Prediction of glycyrrhizin disposition in rat and man by a physiologically based pharmacokinetic model.
Three physiologically based pharmacokinetic models A--C, incorporating enterohepatic recycling, were developed to predict glycyrrhizin (GLZ) disposition in rat plasma and tissues, and human serum. Model A, which included fourteen compartments (artery, vein, tissues except brain, and gut lumen) with the assumption of direct excretion of GLZ from the liver into the gut lumen gave fairly good agreement between the observed and predicted disposition profiles in rat, but was unsuitable in man, where elimination is very rapid. Models B and C for man were obtained by adding a gallbladder compartment (drug storage organ) for the excretion from the liver into the gut lumen and by assuming continuous transfer from the storage compartment or instantaneous emptying from it during meal ingestion as the excretion process from the gallbladder into the gut lumen, respectively. The agreement between the observed and predicted serum concentration time-course profiles was better with model C than model B, especially in the terminal elimination phase, where secondary peaks appeared. However, it was thought that the observed serum disposition can be sufficiently well predicted by model B. In conclusion, prediction in rat was successful in all compartments except the brain, which shows a negligible distribution. Scale-up of the disposition kinetics of GLZ from rat to man was also successful.
Ishida
S
S
Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Japan.
Sakiya
Y
Y
Ichikawa
T
T
Taira
Z
Z
Awazu
S
S
D000818:Animals; D006034:Glycyrrhetinic Acid / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D019695:Glycyrrhizic Acid; D006801:Humans; D008297:Male; D008954:Models, Biological; D051381:Rats; D011919:Rats, Inbred Strains; D014018:Tissue Distribution
D019695:Glycyrrhizic Acid; D006034:Glycyrrhetinic Acid